Regional Meeting Paducah
View Registrations Tell a Friend About This EventTell a Friend
 

Fasenra TM (benralizumab) Subcutaneous Injection 30 mg: A Targeted Approach to Severe Eosinophilic Asthma

1/17/2019
When: Thursday, January 17, 2019
6:00 PM
Where: Cynthia's Ristorante
125 Market House Square
Paducah, Kentucky  42003-8870
United States
Contact: Lisa Oetjen
(270) 564-1797


Online registration is closed.
« Go to Upcoming Event List  

Fasenra TM (benralizumab) Subcutaneous Injection 30 mg:  A Targeted Approach to Severe Eosinophilic Asthma

Offering Number: 1-0018-1-18-

Speaker: Karen Roden, FNP-BC

KBN Contact Hours:  0 of which 0 is Pharmacology Hours

Objectives:  1.  Identify patients with Eosinophilic phenotype that may contribute to severity of asthma control using GINA guidelines.  2.  Introduce Fasenra (benralizumab) as a targeted biologic approach to treating severe asthma in patients with Eosinophilic phenot 

Sponsored by: AstraZeneca

 

 

Fee and Cancellation Policy: This program is free of charge.

Please notify us if your plans change and you will not be able to attend or cancel your reservation online at  http://www.kcnpnm.org/members/manage_profile.asp  Click Events>  More options> Cancel registrant

Note: this will only work if you were signed in when you registered. If you're not sure, call 502.333.0076

KBN Provider No.: 1-0018

more Calendar

3/26/2019
Regional Meeting Ashland

3/26/2019
Regional Meeting Elizabethtown

4/24/2019 » 4/27/2019
Annual Conference 2019-Covington

4/15/2020 » 4/18/2020
Annual Conference 2020/Lexington

4/20/2021 » 4/23/2021
Annual Conference 2021/Louisville

Association Management Software Powered by YourMembership  ::  Legal